3.3700
+0.3320
+(10.93%)
At close: April 17 at 7:31:05 PM GMT+2
Loading Chart for T0A.BE
- Previous Close
3.0380 - Open
3.0360 - Bid 3.1500 x --
- Ask 3.6540 x --
- Day's Range
3.0340 - 3.3700 - 52 Week Range
2.8080 - 12.9300 - Volume
0 - Avg. Volume
0 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date May 7, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: T0A.BE
View MorePerformance Overview: T0A.BE
Trailing total returns as of 4/17/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
T0A.BE
24.94%
S&P/TSX Composite index (^GSPTSE)
1.74%
1-Year Return
T0A.BE
68.36%
S&P/TSX Composite index (^GSPTSE)
11.71%
3-Year Return
T0A.BE
80.11%
S&P/TSX Composite index (^GSPTSE)
10.69%
5-Year Return
T0A.BE
86.84%
S&P/TSX Composite index (^GSPTSE)
68.47%
Compare To: T0A.BE
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
3.3700
+10.93%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
2.4300
-0.82%
Mkt Cap CAD 929.55M
Industry Drug Manufacturers—Specialty & Generic
1.4800
+2.07%
Mkt Cap CAD 197.993M
Industry Drug Manufacturers—Specialty & Generic
1.0700
+2.88%
Mkt Cap 143.144M
Industry Drug Manufacturers—Specialty & Generic
6.14
+2.16%
Mkt Cap CAD 336.988M
Industry Drug Manufacturers—Specialty & Generic
0.6200
-6.06%
Mkt Cap CAD 621.823M
Industry Drug Manufacturers—Specialty & Generic
4.4400
+2.30%
Mkt Cap 243.685M
Industry Drug Manufacturers—Specialty & Generic
1.6300
0.00%
Mkt Cap CAD 297.416M
Industry Drug Manufacturers—Specialty & Generic
1.1900
+0.85%
Mkt Cap 214.562M
Industry Drug Manufacturers—Specialty & Generic
0.4500
-5.42%
Mkt Cap 448.594M
Industry Drug Manufacturers—Specialty & Generic
Statistics: T0A.BE
View MoreValuation Measures
As of 4/17/2025
Market Cap
648.14M
Enterprise Value
1.11B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.61
Price/Book (mrq)
0.58
Enterprise Value/Revenue
1.07
Enterprise Value/EBITDA
4.47
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--